Personal Data
Nationality
American
Year of Birth
1968
Studies
Biochemical Sciences, Harvard Medical School, A.B. 1990
Biochemistry and Molecular Pharmacology, Harvard Medical School, Ph.D. 1999
Medicine, Harvard Medical School, M.D. 1999
Professional Career
1999-2001
Internship and Residency in Internal Medicine, Massachusetts General Hospital
2001
Fellowship in Medical Oncology, Dana-Farber/Partners CancerCare
2003
Chief Resident, Department of Medicine, Massachusetts General Hospital
2004-2005
Research Fellow, Laboratory of William Sellers, Dana-Farber Cancer Institute
2005-2007
Instructor, Laboratory of William Sellers, Dana-Farber Cancer Institute
2007-2011
Assistant Professor of Medicine, Dana-Farber Cancer Institute
2011
Associate Professor of Medicine, Dana-Farber Cancer Institute
2010-2016
Co-Founder and Consultant, Foundation Medicine
2017
Senior Vice-President, Global Oncology, Eli Lilly and Company
2018
Senior Vice-President, Oncology R&D and Novel Target Research, Eli Lilly and Company
2019-current
Executive Vice-President, Head of Global Product Development and Chief Medical Officer, Roche
Institutional Appointments
2002-2007
Instructor, Harvard Medical School
2005-2016
Associate Physician of Medicine, Brigham and Women’s Hospital
2006-2016
Associate Member, Cancer Program, Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard
2006-2016
Member, Biological and Biomedical Sciences Graduate Program, Biological Chemistry & Molecular Pharmacology Dept., Harvard Medical School
2007-2011
Assistant Professor of Medicine, Harvard Medical School
2011-2016
Associate Professor of Medicine, Harvard Medical School
2014-2016
Senior Associate Member, Broad Institute
2014-2016
Institute Member, Broad Institute
2016
Investigator, Howard Hughes Medical Institute
2020-current
Adjunct Professor, Department of Genetics, Stanford University School of Medicine
Prizes and Honors
2003
Partners in Excellence Award
2007
NIH Director’s New Innovator Award
2009
American Society for Clinical Investigation (President, 2015)
2012
Block Award for Outstanding Cancer Research
2013
Paul Marks Prize for Cancer Research
2014
AACR-MICR Jane Cooke Wright Award
2014
Society for Melanoma Research Outstanding Investigator Award
2015
NCI Outstanding Investigator Award
2015
Association of American Physicians
2019
Academy of Fellows, American Association for Cancer Research
2019
Honorary doctorate, Feinstein Institute
2020
National Academy of Medicine
2022
Margaret J. Foti Award for Leadership and Extraordinary Achievement in Cancer Research
2022
Memorial Sloan-Kettering Medal and honorary doctorate, Gerstner/Sloan-Kettering Graduate School of Biomedical Sciences
Corporate Boards
2020-present
Member, Board of Directors, Genentech
2021-present
Member, Board of Directors, Foundation Medicine
2021-present
Member, Board of Directors, Flatiron
Scientific Advisory Boards
2007-2016
Consultant, Novartis Institutes for Biomedical Research
2008-2009
Consultant, Clinical & Translational Research Center, Harvard Medical School
2009-2011
Scientific Task Force, Lymphangioleiomyomatosis (LAM) Treatment Alliance
2011-2016
Member, External Scientific Advisory Board, The Ohio State University Comprehensive Cancer Center
2014-2016
Chair, External Scientific Advisory Board, IGNITE Program, National Human Genome Research Institute (NHGRI)
2015-present
Member, The V Foundation Scientific Advisory Board
2011-present
Member, Board of Scientific Consultants, Memorial Sloan-Kettering Cancer Center
2013-present
Member, External Scientific Advisory Board, MD Anderson Cancer Center
Professional Society Membership
2000-2003
National Medical Association
2007-present
American Association for Cancer Research
2009-present
American Society for Clinical Investigation
2010-present
American Association for the Advancement of Science
2011-2013
American Society for Biochemistry and Molecular Biology
2012-present
American Society for Clinical Oncology
2015-present
Association of American Physicians
2020-present
National Academy of Medicine